Wall Street Lunch: Dan Ives Teams Up With Yorkville Securities To Launch Merchant Bank

Johnson & Johnson beat Q2 estimates and raised guidance, supported by strength in innovative medicines; however, EPS declined, tempering overall sentiment. The analyst commentary additionally points to a new “merchant bank” model via Dan Ives and Yorkville Securities, but the immediate market read-through is driven primarily by the JNJ earnings/guidance versus the EPS headwind.

Analysis

Johnson & Johnson beat Q2 estimates and raised guidance, supported by strength in innovative medicines; however, EPS declined, tempering overall sentiment. The analyst commentary additionally points to a new “merchant bank” model via Dan Ives and Yorkville Securities, but the immediate market read-through is driven primarily by the JNJ earnings/guidance versus the EPS headwind.